Elevated serum tartrate-resistant acid phosphatase isoform 5a levels in metabolic syndrome

Yi Jhih Huang, Tsai Wang Huang, Tsu Yi Chao, Yu Shan Sun, Shyi Jou Chen, Der Ming Chu, Wei Liang Chen, Li Wei Wu

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Tartrate-resistant phosphatase isoform 5a is expressed in tumorassociated macrophages and is a biomarker of chronic inflammation. Herein, we correlated serum tartrate-resistant phosphatase isoform 5a levels with metabolic syndrome status and made comparisons with traditional markers of inflammation, including c-reactive protein and interleukin-6. Methods: One hundred healthy volunteers were randomly selected, and cut-offpoints for metabolic syndrome related inflammatory biomarkers were determined using receiver operating characteristic curves. Linear and logistic regression models were subsequently used to correlate inflammatory markers with the risk of metabolic syndrome. Results: Twenty-two participants met the criteria for metabolic syndrome, and serum tartrate-resistant phosphatase isoform 5a levels of > 5.8 μg/L were associated with metabolic syndrome (c-statistics, 0.730; p = 0.001; 95% confidence interval, 0.618-0.842). In addition, 1 μg/L increases in tartrate-resistant phosphatase isoform 5a levels were indicative of a 1.860 fold increase in the risk of metabolic syndrome (p = 0.012). Conclusions: Elevated serum tartrate-resistant phosphatase isoform 5a levels are associated with the risk of metabolic syndrome, with a cut-offlevel of 5.8 μg/L.

Original languageEnglish
Pages (from-to)78144-78152
Number of pages9
JournalOncotarget
Volume8
Issue number44
DOIs
Publication statusPublished - 2017

Keywords

  • Metabolic syndrome
  • Tartrate-resistant acid phosphatase

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Elevated serum tartrate-resistant acid phosphatase isoform 5a levels in metabolic syndrome'. Together they form a unique fingerprint.

  • Cite this

    Huang, Y. J., Huang, T. W., Chao, T. Y., Sun, Y. S., Chen, S. J., Chu, D. M., Chen, W. L., & Wu, L. W. (2017). Elevated serum tartrate-resistant acid phosphatase isoform 5a levels in metabolic syndrome. Oncotarget, 8(44), 78144-78152. https://doi.org/10.18632/oncotarget.17839